Ring removal in rotary kilns used by the pulp and paper industry von Gorog, J. Peter, Leary, W. Ray

Volltext

Computer modeling as tools to estimate the impact of fuel type on the capacity rating of lime kilns von GOROG, J. PETER, LEARY, W. RAY, WANG, DAVID, DAVIS, KEVIN

Volltext

Design of refractory linings for balanced energy efficiency, uptime, and capacity in lime kilns von GOROG, J. PETER, G. HEMRICK, JAMES, A. WALTER, HARALD, LEARY, W. RAY, ELLIS, MURRAY

Volltext

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer von Miller, R.E., Leary, A., Scott, C.L., Serra, V., Lord, C.J., Bowtell, D., Chang, D.K., Garsed, D.W., Jonkers, J., Ledermann, J.A., Nik-Zainal, S., Ray-Coquard, I., Shah, S.P., Matias-Guiu, X., Swisher, E.M., Yates, L.R.

Volltext

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial von Ray-Coquard, I., Leary, A., Pignata, S., Cropet, C., González-Martín, A., Marth, C., Nagao, S., Vergote, I., Colombo, N., Mäenpää, J., Selle, F., Sehouli, J., Lorusso, D., Guerra Alia, E.M., Bogner, G., Yoshida, H., Lefeuvre-Plesse, C., Buderath, P., Mosconi, A.M., Lortholary, A., Burges, A., Medioni, J., El-Balat, A., Rodrigues, M., Park-Simon, T.-W., Dubot, C., Denschlag, D., You, B., Pujade-Lauraine, E., Harter, P.

Volltext

The Colorectal MicroRNAome von Cummins, Jordan M., He, Yiping, Leary, Rebecca J., Pagliarini, Ray, Diaz, Luis A., Sjoblom, Tobias, Barad, Omer, Bentwich, Zvi, Szafranska, Anna E., Labourier, Emmanuel, Raymond, Christopher K., Roberts, Brian S., Juhl, Hartmut, Kinzler, Kenneth W., Vogelstein, Bert, Velculescu, Victor E.

Volltext

ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease von Ledermann, J.A., Matias-Guiu, X., Amant, F., Concin, N., Davidson, B., Fotopoulou, C., González-Martin, A., Gourley, C., Leary, A., Lorusso, D., Banerjee, S., Chiva, L., Cibula, D., Colombo, N., Croce, S., Eriksson, A.G., Falandry, C., Fischerova, D., Harter, P., Joly, F., Lazaro, C., Lok, C., Mahner, S., Marmé, F., Marth, C., McCluggage, W.G., McNeish, I.A., Morice, P., Nicum, S., Oaknin, A., Pérez-Fidalgo, J.A., Pignata, S., Ramirez, P.T., Ray-Coquard, I., Romero, I., Scambia, G., Sehouli, J., Shapira-Frommer, R., Sundar, S., Tan, D.S.P., Taskiran, C., van Driel, W.J., Vergote, I., Planchamp, F., Sessa, C., Fagotti, A.

Volltext

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours von Leary, A.F., Quinn, M., Fujiwara, K., Coleman, R.L., Kohn, E., Sugiyama, T., Glasspool, R., Ray-Coquard, I., Colombo, N., Bacon, M., Zeimet, A., Westermann, A., Gomez-Garcia, E., Provencher, D., Welch, S., Small, W., Millan, D., Okamoto, A., Stuart, G., Ochiai, K.

Volltext

Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomize... von Banerjee, S., Oza, A.M., Birrer, M.J., Hamilton, E.P., Hasan, J., Leary, A., Moore, K.N., Mackowiak-Matejczyk, B., Pikiel, J., Ray-Coquard, I., Trask, P., Lin, K., Schuth, E., Vaze, A., Choi, Y., Marsters, J.C., Maslyar, D.J., Lemahieu, V., Wang, Y., Humke, E.W., Liu, J.F.

Volltext

Controls on anthropogenic radionuclide distribution in the Sellafield-impacted Eastern Irish Sea von Ray, Daisy, Leary, Peter, Livens, Francis, Gray, Neil, Morris, Katherine, Law, Kathleen A., Fuller, Adam J., Abrahamsen-Mills, Liam, Howe, John, Tierney, Kieran, Muir, Graham, Law, Gareth T.W.

Volltext

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease von Ledermann, JA, Matias-Guiu, X, Amant, F, Concin, N, Davidson, B, Fotopoulou, C, González-Martin, A, Gourley, C, Leary, A, Lorusso, D, Banerjee, S, Chiva, L, Cibula, D, Colombo, N, Croce, S, Eriksson, AG, Falandry, C, Fischerova, D, Harter, P, Joly, F, Lazaro, C, Lok, C, Mahner, S, Marmé, F, Marth, C, McCluggage, WG, McNeish, IA, Morice, P, Nicum, S, Oaknin, A, Pérez-Fidalgo, JA, Pignata, S, Ramirez, PT, Ray-Coquard, I, Romero, I, Scambia, G, Sehouli, J, Shapira-Frommer, R, Sundar, S, Tan, DSP, Taskiran, C, Van Driel, WJ, Vergote, I, Planchamp, F, Sessa, C, Fagotti, A

Volltext

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial von Ray-Coquard, I, Leary, A, Pignata, S, Cropet, C, Gonzalez-Martin, A, Marth, C, Nagao, S, Vergote, I, Colombo, N, Maenpaa, J, Selle, F, Sehouli, J, Lorusso, D, Alia, E.M. Guerra, Bogner, G, Yoshida, H, Lefeuvre-Plesse, C, Buderath, P, Mosconi, A.M, Lortholary, A, Burges, A, Medioni, J, El-Balat, A, Rodrigues, M, Park-Simon, T.-W, Dubot, C, Denschlag, D, You, B, Pujade-Lauraine, E, Harter, P

Volltext

Atezolizumab combined with bevacizumab and platinum-based therapy for platinum-sensitive ovarian cancer : placebo-controlled randomized phase III ATALANTE/ENGOT-ov29 trial von Pujade-Lauraine, Eric, Cibula, David, Rodrigues, Manuel, Martinez García, Jeronimo, Kocián, Roman, Vergote, Ignace, Lebreton, Coriolan, Lotz, Jean-Pierre, Heitz, Florian, Abadie-Lacourtoisie, S, Alexandre, J, Azemar, M, Baba-Hamed, N, Bally, O, Barriere, J, Bazan, F, Bonnin, N, Boughalem, E, Boustany Grenier, R, Brachet, P.-E, Brocard, F, Bultot-Boissier, E, Cappiello-Bataller, M.A, Castanie, H, Chakiba, C, Chocteau-Bouju, D, Coquan, E, Costan, C, Crouzet, L, Dauba, J, Dawood, H, De Cock, L, Debelleix, C, Delbaldo, C, Demarchi, M, Despax, R, D'Hondt, V, Donnadieu, A, Fabbro, M, Falandry, C, Fiteni, F, Follana, P, Freyer, G, Gladieff, L, Joly, F, Jouinot, A, Kalbacher, E, Kaminsky, M.-C, Lancry-Lecomte, L, Largillier, R, Le Du, F, Leary, A, Lebreton, C, Lesoin, A, Lortholary, A, Martin-Babau, J, Meriaux, E, Meunier, J, Moïse, L, Pautier, P, Peron, J, Perrin, C, Provansal, M, Raban, N, Ray-Coquard, I, Regnault De La Mothe, P, Riedl, C, Roemer-Becuwe, C, Sabatier, R, Sebbag, C, Sverdlin, R, Timar-David, M, You, B, Buderath, P, De Gregorio, N, Fehm, T, Grischke, E.-M, Gropp-Meier, M, Hartkopf, A, Runnebaum, I, Schnappauf, B, Sehouli, J, Trillsch, F, Wimberger, P, Oaknin, A, Alarcon, J.D, Alonso, S, Alonso Herrero, A, Casado, A, Churruca, C, Fernandez, I, Gaba, L, Garcia-Donas, J, Gonzalez, S, Marquina, G, Martinez-García, J, Marth, C, Cibula, D, Vergote, I, Rosengarten, O

Volltext

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer von Miller, RE, Leary, A, Scott, CL, Serra, V, Lord, CJ, Bowtell, D, Chang, DK, Garsed, DW, Jonkers, J, Ledermann, JA, Nik-Zainal, S, Ray-Coquard, I, Shah, SP, Matias-Guiu, X, Swisher, EM, Yates, LR

Volltext bestellen

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer von Miller, RE, Leary, A, Scott, CL, Serra, V, Lord, CJ, Bowtell, D, Chang, DK, Garsed, DW, Jonkers, J, Ledermann, JA, Nik-Zainal, S, Ray-Coquard, I, Shah, SP, Matias-Guiu, X, Swisher, EM, Yates, LR

Volltext bestellen

URV ESPRIT for tracking time-varying signals von Liu, K.J. Ray, O'Leary, D.P., Stewart, G.W., Wu, Y.-J.J.

Volltext